Episode Details

In our latest TDR Cannabis in Five presented by Flowhub, host Shadd Dales breaks down what Trulieve’s (NYSE: TRLV) historic move to the New York Stock Exchange actually means for the cannabis industry—and why investors should be looking beyond the headlines.The uplisting marked a major milestone as Trulieve became the first U.S. plant-touching cannabis operator to trade on the NYSE. But the story didn’t end there. Shortly after the listing, attention shifted to CEO Kim Rivers’ pre-scheduled share sales, raising questions from investors about timing, perception, and what it all means going forward.The episode also looks at which companies could be next. Curaleaf (TSX: CURA | OTCQX: CURLF) and Verano (Cboe Canada: VRNO | OTCQX: VRNOF) have already completed reverse stock splits, signaling preparations for potential uplistings. Green Thumb Industries (CSE: GTII | OTCQX: GTBIF) remains one of the sector’s strongest operators, while Cresco Labs (CSE: CL | OTCQX: CRLBF) continues to generate speculation around consolidation and M&A.Most importantly, this episode explains why an uplisting alone doesn’t solve the industry’s biggest challenges. The discussion covers institutional capital, liquidity, valuation, balance sheets, and why the second company to reach a major U.S. exchange could be just as important as the first.#Cannabis #CannabisStocks #Trulieve #ScheduleIII #NYSE #MSOS #CannabisInvesting #CannabisNews #WallStreet #CannabisIndustryWant to see last week's recap?   • ALJ Hearing Begins Tomorrow | TTB Weekly R...  Want to see more Cannabis Reform?🎬    • Who’s Really Testifying At The ALJ Hearing...  🎬    • What Investors Are Missing About The ALJ H...  🎬    • Virginia Cannabis Legalization Back On Tra...  🎬    • Lawsuit Targets Cannabis Rescheduling Proc...  Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:

Listen Now